Exploring the roles of autophagy in the nervous system. (360G-Wellcome-095317_Z_11_A)
Intracellular protein misfolding/aggregation characterises many late-onset neurodegenerative diseases, including Alzheimer s disease, Parkinson s disease, tauopathies, and Huntington s disease (HD)). The mutations causing HD and many related diseases confer novel toxic functions on the specific protein. Thus, it is important to understand the factors regulating the levels of these proteins. (Macro) autophagy clears long-lived proteins and organelles by forming autophagosomes that engulf p ortions of cytoplasm. Autophagosomes ultimately fuse with lysosomes, where their contents are degraded. Autophagy regulates the levels of intracytoplasmic aggregate-prone proteins that cause neurodegenerative diseases, including HD. Autophagy upregulation may attenuate diseases like HD, and possibly tuberculosis. Autophagy inhibition slows growth of existing tumors, and may also contribute to pathology in various neurodegenerative diseases. I aim to: Discover novel autophagy-modulating dr ugs/pathways and test their clinical relevance in models of neurodegenerative diseases, tuberculosis and cancer. Test if there are beneficial/deleterious effects of constitutive autophagy upregulation in vertebrates. Develop methods to infer autophagic flux in vivo. Understand how autophagy compromise causes pathology. Identify novel autophagy-regulating mechanisms and investigate possible disease relevance. These studies will help the understanding of the relationship betwee n autophagy, normal physiology and disease, and will provide proof-of-principle for autophagy-modulating strategies as therapies for a range of conditions.
Where is this data from?
This data was originally published by The Wellcome Trust. If you see something about your organisation or the funding it has received on this page that doesn't look right you can submit a grantee amendment request. You can hover over codes from standard codelists to see the user-friendly name provided by 360Giving.
Grant Details
Amount Awarded | 350000 |
Applicant Surname | Rubinsztein |
Approval Committee | Science Enhancement Committee |
Award Date | 2013-10-03T00:00:00+00:00 |
Financial Year | 2013/14 |
Grant Programme: Title | Enhancement |
Internal ID | 095317/Z/11/A |
Lead Applicant | Prof David Rubinsztein |
Partnership Value | 350000 |
Planned Dates: End Date | 2016-12-31T00:00:00+00:00 |
Planned Dates: Start Date | 2014-01-01T00:00:00+00:00 |
Recipient Org: Country | United Kingdom |
Region | East of England |